Elevated Serum Uric Acid/Albumin Ratio as a Predictor of Post-Contrast Acute Kidney Injury After Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction

References

• Azzalini L, Candilio L, McCullough PA, Colombo A. Current risk of contrast-induced acute kidney injury after coronary angiography and intervention: a reappraisal of the literature. Can J Cardiol. 2017;33(10):1225–1228. doi:10.1016/j.cjca.2017.07.482
   PubMed Web of Science ®Google Scholar
• Silvain J, Nguyen LS, Spagnoli V, et al. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2018;104(9):767–772. doi:10.1136/heartjnl-2017-311975
   PubMed Web of Science ®Google Scholar
• Van der Molen AJ, Dekkers IA, Bedioune I, Darmon-Kern E. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2-intra-arterial administration. Eur Radiol. 2022. doi:10.1007/s00330-022-08637-2
   Web of Science ®Google Scholar
• He H, Chen XR, Chen YQ, Niu TS, Liao YM. Prevalence and predictors Of Contrast-Induced Nephropathy (CIN) in patients with ST-Segment Elevation Myocardial Infarction (STEMI) undergoing Percutaneous Coronary Intervention (PCI): a meta-analysis. J Interv Cardiol. 2019;2019:2750173. doi:10.1155/2019/2750173
   PubMed Web of Science ®Google Scholar
• Efe SC, Keskin M, Toprak E, et al. A novel risk assessment model using urinary system contrast blush grading to predict contrast-induced acute kidney injury in low-risk profile patients. Angiology. 2021;72(6):524–532. doi:10.1177/00033197211005206
   PubMed Web of Science ®Google Scholar
• Shacham Y, Gal-Oz A, Flint N, Keren G, Arbel Y. Serum uric acid levels and renal impairment among ST-segment elevation myocardial infarction patients undergoing primary percutaneous intervention. Cardiorenal Med. 2016;6(3):191–197. doi:10.1159/000444100
   PubMed Web of Science ®Google Scholar
• Mandurino-Mirizzi A, Kajana V, Cornara S, et al. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2021;31(7):2140–2143. doi:10.1016/j.numecd.2021.04.002
   PubMed Web of Science ®Google Scholar
• Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437. doi:10.1111/j.0894-0959.2004.17603.x
   PubMed Web of Science ®Google Scholar
• Sitar ME, Aydin S, Cakatay U. Human serum albumin and its relation with oxidative stress. Clin Lab. 2013;59(9–10):945–952. doi:10.7754/Clin.Lab.2012.121115
   PubMed Web of Science ®Google Scholar
• Fujii R, Ueyama J, Kanno T, et al. Human serum albumin redox state is associated with decreased renal function in a community-dwelling population. Am J Physiol Renal Physiol. 2019;316(1):F214–F218. doi:10.1152/ajprenal.00138.2018
   PubMed Web of Science ®Google Scholar
• Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020;18(1):400. doi:10.1186/s12967-020-02574-8
   PubMed Web of Science ®Google Scholar
• Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379. doi:10.1016/j.lfs.2020.118379
   PubMed Web of Science ®Google Scholar
• Ösken A, Öz A, Keskin M, et al. The association between neutrophil-to-lymphocyte ratio and contrast-induced acute kidney injury in patients with carotid artery stenting. Vascular. 2021;29(4):550–555. doi:10.1177/17085381211012562
   PubMed Web of Science ®Google Scholar
• Zdziechowska M, Gluba-Brzózka A, Franczyk B, Rysz J. Biochemical markers in the prediction of contrast-induced acute kidney injury. Curr Med Chem. 2021;28(6):1234–1250. doi:10.2174/0929867327666200502015749
   PubMed Web of Science ®Google Scholar
• Yeter HH, Eyupoglu D, Pasayev T, Cetik S, Akcay OF, Yildirim T. Role of uric acid albumin ratio in predicting development of acute kidney injury and mortality in intensive care unit patients. Turkish J Nephrol. 2019;28:160–167. doi:10.5152/turkjnephrol.2019.3416
   Web of Science ®Google Scholar
• Özgür Y, Akın S, Yılmaz NG, Gücün M, Keskin Ö. Uric acid albumin ratio as a predictive marker of short-term mortality in patients with acute kidney injury. Clin Exp Emerg Med. 2021;8(2):82–88. doi:10.15441/ceem.20.024
   PubMed Web of Science ®Google Scholar
• Şaylık F, Çınar T, Akbulut T, Selçuk M. Serum uric acid to albumin ratio can predict contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Angiology. 2022;33197221091605. doi:10.1177/00033197221091605
   Web of Science ®Google Scholar
• Slocum NK, Grossman PM, Moscucci M, et al. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the blue cross blue shield of Michigan cardiovascular consortium (BMC2). Am Heart J. 2012;163(5):829–834. doi:10.1016/j.ahj.2012.02.011
   PubMed Web of Science ®Google Scholar
• Marenzi G, Cosentino N, Moltrasio M, et al. Acute kidney injury definition and in-hospital mortality in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Am Heart Assoc. 2016;5(7):e003522. doi:10.1161/JAHA.116.003522
   PubMed Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart association task force on practice guidelines. J Am Coll Cardiol. 2013;61(4):e78–e140. doi:10.1016/j.jacc.2012.11.019
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254. doi:10.7326/0003-4819-145-4-200608150-00004
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol. 2011;21(12):2527–2541. doi:10.1007/s00330-011-2225-0
   PubMed Web of Science ®Google Scholar
• Ejaz AA, Johnson RJ, Shimada M, et al. The role of uric acid in acute kidney injury. Nephron. 2019;142(4):275–283. doi:10.1159/000499939
   PubMed Web of Science ®Google Scholar
• Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med. 2010;36(10):1657–1665. doi:10.1007/s00134-010-1928-z
   PubMed Web of Science ®Google Scholar
• Barbieri L, Verdoia M, Schaffer A, et al. Uric acid levels and the risk of contrast induced nephropathy in patients undergoing coronary angiography or PCI. Nutr Metab Cardiovasc Dis. 2015;25(2):181–186. doi:10.1016/j.numecd.2014.08.008
   PubMed Web of Science ®Google Scholar
• Guo W, Liu Y, Chen JY, et al. Hyperuricemia is an independent predictor of contrast-induced acute kidney injury and mortality in patients undergoing percutaneous coronary intervention. Angiology. 2015;66(8):721–726. doi:10.1177/0003319714568516
   PubMed Web of Science ®Google Scholar
• Zuo T, Jiang L, Mao S, Liu X, Yin X, Guo L. Hyperuricemia and contrast-induced acute kidney injury: a systematic review and meta-analysis. Int J Cardiol. 2016;224:286–294. doi:10.1016/j.ijcard.2016.09.033
   PubMed Web of Science ®Google Scholar
• Murat SN, Kurtul A, Yarlioglues M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2015;66(8):732–737. doi:10.1177/0003319714551979
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun WJ, Ji ZS, Liu CB, Wang R. Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention. Rev Cardiovasc Med. 2020;21(1):139–145. doi:10.31083/j.rcm.2020.01.583
   PubMed Web of Science ®Google Scholar
• Kalkan S, Cagan Efe S, Karagöz A, et al. A new predictor of mortality in ST-elevation myocardial infarction: the uric acid albumin ratio. Angiology. 2022;73(5):461–469. doi:10.1177/00033197211066362
   PubMed Web of Science ®Google Scholar
• Çakmak EÖ, Bayam E, Çelik M, et al. Uric acid-to-albumin ratio: a novel marker for the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Pulse. 2021;8(3–4):99–107. doi:10.1159/000514533
   PubMed Web of Science ®Google Scholar
• Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011;219(1):334–341. doi:10.1016/j.atherosclerosis.2011.07.021
   PubMed Web of Science ®Google Scholar
• Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012;109(4):486–491. doi:10.1016/j.amjcard.2011.09.042
   PubMed Web of Science ®Google Scholar
• Ranjith N, Myeni NN, Sartorius B, Mayise C. Association between hyperuricemia and major adverse cardiac events in patients with acute myocardial infarction. Metab Syndr Relat Disord. 2017;15(1):18–25. doi:10.1089/met.2016.0032
   PubMed Web of Science ®Google Scholar
• Baumann S, Huseynov A, Koepp J, et al. Comparison of serum uric acid, Bilirubin, and C-reactive protein as prognostic biomarkers of in-hospital MACE between women and men with ST-segment elevation myocardial infarction. Angiology. 2016;67(3):272–280. doi:10.1177/0003319715589246
   PubMed Web of Science ®Google Scholar
• Matsumoto I, Moriya S, Kurozumi M, Namba T, Takagi Y. Relationship between serum uric acid levels and the incidence of cardiovascular events after percutaneous coronary intervention. J Cardiol. 2021;78(6):550–557. doi:10.1016/j.jjcc.2021.08.005
   PubMed Web of Science ®Google Scholar
• Bicciré FG, Pastori D, Tanzilli A, et al. Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction. Nutr Metab Cardiovasc Dis. 2021;31(10):2904–2911. doi:10.1016/j.numecd.2021.06.003
   PubMed Web of Science ®Google Scholar
• Khraishah H, Alahmad B, Secemsky E, et al. Comparative effectiveness of reperfusion strategies in patients with st-segment elevation myocardial infarction: a secondary analysis of the acute coronary syndrome quality improvement in Kerala (ACS QUIK) Trial. Glob Heart. 2020;15(1):68. doi:10.5334/gh.868
   PubMed Web of Science ®Google Scholar
• Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145–4151. doi:10.2174/138161205774913255
   PubMed Web of Science ®Google Scholar
• Crawley WT, Jungels CG, Stenmark KR, Fini MA. U-shaped association of uric acid to overall-cause mortality and its impact on clinical management of hyperuricemia. Redox Biol. 2022;51:102271. doi:10.1016/j.redox.2022.102271
   PubMed Web of Science ®Google Scholar
• Magnoni M, Berteotti M, Ceriotti F, et al. Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. Int J Cardiol. 2017;240:25–29. doi:10.1016/j.ijcard.2017.04.027
   PubMed Web of Science ®Google Scholar
• Mandurino-Mirizzi A, Demarchi A, Ruffinazzi M, et al. Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. J Cardiovasc Med. 2020;21(4):337–339. doi:10.2459/JCM.0000000000000926
   Google Scholar
• Mandurino-Mirizzi A, Cornara S, Somaschini A, et al. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Nutr Metab Cardiovasc Dis. 2021;31(2):608–614. doi:10.1016/j.numecd.2020.10.020
   PubMed Web of Science ®Google Scholar
• Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology. 2005;41(6):1211–1219. doi:10.1002/hep.20720
   PubMed Web of Science ®Google Scholar
• Lam FW, Cruz MA, Leung HC, Parikh KS, Smith CW, Rumbaut RE. Histone induced platelet aggregation is inhibited by normal albumin. Thromb Res. 2013;132(1):69–76. doi:10.1016/j.thromres.2013.04.018
   PubMed Web of Science ®Google Scholar